Bridging the Gap Between Preclinical Studies and Clinical Development – Fih Phase 0 Studies
Time: 4:30 pm
day: Conference Day 2
Details:
- Exploring the Role of Phase 0 Studies: Understanding the significance of Phase 0 studies in the development of targeted radiopharmaceuticals (TRP) and their role as a crucial intermediate step between preclinical research and Phase 1/2 clinical trials
- Advantages and Challenges: Discussing the advantages and challenges associated with conducting Phase 0 studies, including their potential to accelerate drug development, provide early human data, and optimize in-human studies while managing risks effectively
- Conducting, and interpreting Phase 0 studies for TRPs, emphasizing their impact on decision-making and successful translation to clinical trials
